147P Genomic Profile and Response Prediction of Eribulin Mesylate-Based Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients

T. Nishimura,N. Masuda,K. Kawaguchi,M. Takada,Y. Maeshima,S. Tanaka, R. Velaga,Y. Kikawa,T. Kadoya,H. Bando,R. Nakamura, Y. Yamamoto,T. Ueno,H. Yasojima,H. Ishiguro,S. Morita,S. Ohno,H. Haga, S. Ogawa,M. Toi

Annals of oncology（2021）

Cited 0|Views37
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined